Studies in non-small cell lung cancer tumors showed that ELMO3 expression is higher in patients with metastasis than in normal lung tissue and patients without metastasis indicating a poor prognosis for patients with high ELMO3 expression [9]. This evidence concerns the gene ELMO3 and non-small cell lung carcinoma.